* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 5566 | PRKACA | C0334287 | Fibrolamellar hepatocellular carcinoma | 0.201373633921065 | BEFREE;ORPHANET |
| 5566 | PRKACA | C0001624 | Adrenal Gland Neoplasms | 0.200824180352639 | BEFREE;CTD_human |
| 5566 | PRKACA | C1621895 | Adrenal hyperplasia | 0.200549453568426 | BEFREE;HPO |
| 5566 | PRKACA | C0002170 | Alopecia | 0.2 | HPO |
| 5566 | PRKACA | C0011581 | Depressive disorder | 0.2 | HPO |
| 5566 | PRKACA | C0011849 | Diabetes Mellitus | 0.2 | HPO |
| 5566 | PRKACA | C0013491 | Ecchymosis | 0.2 | HPO |
| 5566 | PRKACA | C0015672 | Fatigue | 0.2 | HPO |
| 5566 | PRKACA | C0019572 | Hirsutism | 0.2 | HPO |
| 5566 | PRKACA | C0020538 | Hypertensive disease | 0.2 | HPO |
| 5566 | PRKACA | C0020619 | Hypogonadism | 0.2 | HPO |
| 5566 | PRKACA | C0029453 | Osteopenia | 0.2 | HPO |
| 5566 | PRKACA | C0029456 | Osteoporosis | 0.2 | HPO |
| 5566 | PRKACA | C0043094 | Weight Gain | 0.2 | HPO |
| 5566 | PRKACA | C0085633 | Mood swings | 0.2 | HPO |
| 5566 | PRKACA | C0151786 | Muscle Weakness | 0.2 | HPO |
| 5566 | PRKACA | C0152459 | Linear atrophy | 0.2 | HPO |
| 5566 | PRKACA | C0206698 | Cholangiocarcinoma | 0.2 | CTD_human |
| 5566 | PRKACA | C0221629 | Proximal muscle weakness | 0.2 | HPO |
| 5566 | PRKACA | C0234958 | muscle degeneration | 0.2 | HPO |
| 5566 | PRKACA | C0241181 | Fragile skin | 0.2 | HPO |
| 5566 | PRKACA | C0270948 | Neurogenic Muscular Atrophy | 0.2 | HPO |
| 5566 | PRKACA | C0349588 | Short stature | 0.2 | HPO |
| 5566 | PRKACA | C0423757 | Thin skin | 0.2 | HPO |
| 5566 | PRKACA | C0423798 | Increased tendency to bruise | 0.2 | HPO |
| 5566 | PRKACA | C0497247 | Increase in blood pressure | 0.2 | HPO |
| 5566 | PRKACA | C0541794 | Skeletal muscle atrophy | 0.2 | HPO |
| 5566 | PRKACA | C0702166 | Acne | 0.2 | HPO |
| 5566 | PRKACA | C0747078 | Generalized osteopenia | 0.2 | HPO |
| 5566 | PRKACA | C1390474 | Increased susceptibility to fractures | 0.2 | HPO |
| 5566 | PRKACA | C1838869 | Proximal neurogenic muscle weakness | 0.2 | HPO |
| 5566 | PRKACA | C1843479 | Neurogenic muscle atrophy, especially in the lower limbs | 0.2 | HPO |
| 5566 | PRKACA | C1850573 | Slender build | 0.2 | HPO |
| 5566 | PRKACA | C1968851 | Pigmented micronodular adrenocortical disease | 0.2 | HPO |
| 5566 | PRKACA | C1968852 | ACTH-independent hypercortisolemia | 0.2 | HPO |
| 5566 | PRKACA | C4014425 | PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4 | 0.2 | UNIPROT |
| 5566 | PRKACA | C4025760 | Primary hypercorticolism | 0.2 | HPO |
| 5566 | PRKACA | C0007786 | Brain Ischemia | 0.08 | RGD |
| 5566 | PRKACA | C1458155 | Mammary Neoplasms | 0.0054658249296275 | LHGDN |
| 5566 | PRKACA | C0002395 | Alzheimer's Disease | 0.00273291246481375 | LHGDN |
| 5566 | PRKACA | C0003130 | Anoxia | 0.00273291246481375 | LHGDN |
| 5566 | PRKACA | C0020429 | Hyperalgesia | 0.00273291246481375 | LHGDN |
| 5566 | PRKACA | C0033578 | Prostatic Neoplasms | 0.00273291246481375 | LHGDN |
| 5566 | PRKACA | C0919267 | ovarian neoplasm | 0.00273291246481375 | LHGDN |
| 5566 | PRKACA | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.00273291246481375 | LHGDN |
| 5566 | PRKACA | C0342443 | Adrenal Cushing's syndrome | 0.0024725410579179 | BEFREE |
| 5566 | PRKACA | C0010481 | Cushing Syndrome | 0.0021978142737048 | BEFREE |
| 5566 | PRKACA | C0001430 | Adenoma | 0.0013736339210655 | BEFREE |
| 5566 | PRKACA | C0206667 | Adrenal Cortical Adenoma | 0.0013736339210655 | BEFREE |
| 5566 | PRKACA | C0001622 | Adrenal Gland Hyperfunction | 0.0005494535684262 | BEFREE |
| 5566 | PRKACA | C0001627 | Congenital adrenal hyperplasia | 0.0005494535684262 | BEFREE |
| 5566 | PRKACA | C0032019 | Pituitary Neoplasms | 0.0005494535684262 | BEFREE |
| 5566 | PRKACA | C0342492 | Adrenal hypertrophy or hyperplasia | 0.0005494535684262 | BEFREE |
| 5566 | PRKACA | C0006142 | Malignant neoplasm of breast | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0008626 | Congenital chromosomal disease | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0151468 | Thyroid Gland Follicular Adenoma | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0175754 | Agenesis of corpus callosum | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0206686 | Adrenocortical carcinoma | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0282160 | Aplasia Cutis Congenita | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0376358 | Malignant neoplasm of prostate | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0600139 | Prostate carcinoma | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0678222 | Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C0858864 | spot pigmented | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C1306214 | ACTH-Secreting Pituitary Adenoma | 0.0002747267842131 | BEFREE |
| 5566 | PRKACA | C2239176 | Liver carcinoma | 0.0002747267842131 | BEFREE |